Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BICALUTAMIDE vs BIMEKIZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BICALUTAMIDE vs BIMEKIZUMAB: Safety Overview

Metric BICALUTAMIDE BIMEKIZUMAB
Total FAERS Reports 4,061 2,459
Deaths Reported 462 31
Death Rate 11.4% 1.3%
Hospitalizations 1,486 565
Average Patient Age 71.9 yrs 52.9 yrs
% Female Patients 2.1% 59.9%
FDA Approval Date Aug 28, 2009 N/A
Manufacturer Proficient Rx LP UCB, Inc.
Route ORAL SUBCUTANEOUS
Marketing Status Prescription N/A